What Does MOTS-c Do for Energy and Body Composition?

MOTS-c helped mice burn more energy and resist diet-related weight gain. In people, blood levels rise briefly after exercise and drift down with age, and a 4-week study of a MOTS-c-like drug lowered glucose with only a slight trend toward lower weight. It looks like an energy signal, not a proven way to lose fat or reshape your body.

How does MOTS-c change energy use?

MOTS-c is a small peptide, a protein piece made of 16 amino acids, that is made inside mitochondria, the parts of cells that turn food into usable energy. It acts mainly on skeletal muscle.

In mice, 7 days of MOTS-c improved insulin sensitivity before body weight changed, so muscle took up glucose more readily mouse study in Cell Metabolism.

With longer treatment, the mice burned more energy and produced more heat. They gained less weight and stayed more sensitive to insulin on a high-fat diet and with aging. The researchers linked this to activation of AMPK, a cell signal that tells muscle to burn fuel mouse study in Cell Metabolism.

What has been seen in people so far?

In people, MOTS-c behaves like a short exercise signal. Plasma levels rose after a bout of acute exercise, and in mice treatment supported physical capacity and steadier metabolism exercise study in Nature Communications.

A study of 85 adults found no difference in fasting blood MOTS-c between those with obesity and those at normal weight. Levels fell with age and rose along with HOMA-IR, a blood calculation used as a marker of insulin resistance 85-adult observational study.

When researchers tested CB4211, a lab-made version of MOTS-c, in 88 people, the drug was well tolerated with no serious adverse events. In the 4-week part in adults with obesity and fatty liver disease, glucose fell and weight showed only a slight downward trend, not clear weight loss CB4211 Phase 1a/1b topline results.

Is it a body-composition treatment yet?

A 2023 review found that MOTS-c moves to the cell nucleus under metabolic stress and supports glucose use in muscle, but it stated that doctors still have no established way to give it as treatment 2023 MOTS-c review.

A Phase 2a trial listed as NCT07505745 is now testing MOTS-c itself in adults with prediabetes and overweight or obesity 2026 trial summary.

If steady energy and less midlife weight gain are your goals now, the HOD quiz can match you to a clinician-reviewed plan available through HOD.